CN110123498A - A kind of enteron aisle internal bypass bracket component and its fixing means - Google Patents
A kind of enteron aisle internal bypass bracket component and its fixing means Download PDFInfo
- Publication number
- CN110123498A CN110123498A CN201810134821.2A CN201810134821A CN110123498A CN 110123498 A CN110123498 A CN 110123498A CN 201810134821 A CN201810134821 A CN 201810134821A CN 110123498 A CN110123498 A CN 110123498A
- Authority
- CN
- China
- Prior art keywords
- bracket
- enteron aisle
- protruding portion
- intestinal
- internal bypass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/848—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/821—Ostial stents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
本发明公开了一种肠道内旁路支架组件及其固定方法,具体地,该肠道内旁路支架组件包括支架和固定件;支架具有通孔和支架壁,支架壁包含第一突出部、第二突出部和固定部,固定部位于第一突出部和第二突出部之间;固定件为硬质环形结构;设第一突出部的外径和第二突出部的外径中的最小值为d1,固定部的外径为d2,固定件的内径为d3,则d1>d3>d2;使用时,支架位于肠道内,固定件套于肠道外并且卡套在支架的固定部对应的位置以固定肠道内的支架。本发明操作简便,安全可靠地固定用于保护直肠吻合口的保护套,且能够避免在使用过程中对肠管造成损伤。
The invention discloses an intestinal bypass bracket assembly and a fixing method thereof. Specifically, the intestinal bypass bracket assembly includes a bracket and a fixing piece; the bracket has a through hole and a bracket wall, and the bracket wall includes a first protrusion, a second Two protruding parts and a fixed part, the fixed part is located between the first protruding part and the second protruding part; the fixing part is a hard ring structure; the minimum value of the outer diameter of the first protruding part and the outer diameter of the second protruding part is established is d 1 , the outer diameter of the fixing part is d 2 , and the inner diameter of the fixing part is d 3 , then d 1 > d 3 > d 2 ; when in use, the stent is located in the intestinal tract, the fixing part is set outside the intestinal tract and inserted into the stent The corresponding position of the fixing part is used to fix the stent in the intestinal tract. The invention is easy to operate, securely and reliably fixes the protective sheath used to protect the anastomosis of the rectum, and can avoid damage to the intestinal tube during use.
Description
技术领域technical field
本发明涉及医疗器械领域,更具体地涉及一种肠道内旁路支架组件及其固定方法。The invention relates to the field of medical devices, and more particularly to an intestinal bypass support assembly and a fixing method thereof.
背景技术Background technique
各种支架在消化道的应用已经有较长时间,无论支架是硬质的、软质的、气囊或水囊的、覆膜网状的、记忆合金的,也不论支架是到达位置后扩张的、还是两端有扩张性结构的,在食管、贲门、胆道、有狭窄性病变的结肠都可以置入,虽有一定移位机率,但总体尚可满意。但是目前各种支架在正常结构功能的结肠却无法停留,这是由于结肠的特殊结构和运动方式决定的。Various stents have been used in the digestive tract for a long time, no matter whether the stent is hard, soft, air bag or water bag, covered mesh, memory alloy, or whether the stent is expanded after reaching the position , or have dilated structures at both ends, and can be placed in the esophagus, cardia, biliary tract, and colon with strictures. Although there is a certain probability of displacement, it is generally satisfactory. However, at present, various stents cannot stay in the colon with normal structure and function, which is determined by the special structure and movement mode of the colon.
结肠的肠壁肌肉分为内环肌和外纵肌,其中外纵肌比结肠浆膜纵行短,因而形成“结肠袋”,这使结肠有较大的扩张性,一般的扩张性支架难以停留。同时,结肠的蠕动分三种:一种是空腹时的袋状往返运动,这使得一端膨胀的支架难以停留;二是进食后引起的多袋推进运动,此时外纵肌会有明显的局部增厚,造成对肠壁内外侧面的压力;三是运动距离较长的收缩波,收缩波前方的肌肉舒张,这也使得扩张性的支架难以停留。The intestinal wall muscles of the colon are divided into inner circular muscles and outer longitudinal muscles. The outer longitudinal muscles are shorter than the longitudinal length of the colon serosa, thus forming a "colon bag", which makes the colon more expandable, and it is difficult for ordinary expandable stents to stay. At the same time, there are three types of colonic peristalsis: one is pouch-like reciprocating movement during fasting, which makes it difficult for the stent expanded at one end to stay; The thickening causes pressure on the inner and outer sides of the intestinal wall; the third is the contraction wave with a long movement distance, and the muscles in front of the contraction wave relax, which also makes it difficult for the expandable stent to stay.
目前结肠和直肠切除后面临两大难点问题:问题之一:结肠和直肠部分肠管切除后的吻合口,由于肠内黏膜面有无法去除的大肠杆菌存在,发生吻合口小脓肿和瘘的概率远大于其他消化道吻合口,所以对于乙状结肠和直肠切除后的吻合口保护问题长久以来一直是国内外结直肠手术研究的热点之一。以往的消化道支架是为了治疗病变局部的狭窄,在正常结肠中很少使用。但是自上世纪90年代就不断有专利和文章阐述一种叫做“肠道内旁路装置”的概念,意思是将一个软性薄膜管道固定于结肠内吻合口上方,薄膜管道上端与一个结肠内支架连接,支架的某一部位与结肠黏膜之间紧密接触,从而使肠内容物流入软性管道内直接排出肛门,大肠杆菌不会污染软性管道所隔离的吻合口,达到减少吻合口脓肿和瘘的目的。但是,该装置至今未在临床出现,其原因就是难以将该薄膜管道在不损伤肠壁的情况下留置于结肠内。问题之二:在直肠癌临床治疗中,低位和极低位保留肛门的手术日渐成熟。但是在切除肛门内括约肌后,也就是实行了括约肌间切除术(IRS)后,临时性大便失禁的发生率非常高,综合文献数据为3个月内发生率为70-80%,但是三个月后恢复率为90%。该情况造成患者在术后几个月内处于大便失禁的状态,即便带纸尿裤也是无法防止异味和局部污秽。At present, there are two difficult problems after the resection of the colon and rectum: one of the problems: the anastomosis after the resection of part of the colon and rectum, due to the existence of E. Therefore, the protection of the anastomosis after the resection of the sigmoid colon and rectum has long been one of the hot spots in the research of colorectal surgery at home and abroad. In the past, gastrointestinal stents were used to treat local stenosis and were rarely used in normal colons. However, since the 1990s, there have been patents and articles explaining a concept called "intestinal bypass device", which means that a soft membrane tube is fixed above the anastomosis in the colon, and the upper end of the membrane tube is connected with a colonic stent Connection, a certain part of the stent is in close contact with the colonic mucosa, so that the intestinal content flows into the soft tube and is directly discharged out of the anus, and E. coli will not contaminate the anastomosis isolated by the soft tube, so as to reduce anastomotic abscess and fistula the goal of. However, this device has not appeared clinically so far, and the reason is that it is difficult to indwell the thin film tube in the colon without damaging the intestinal wall. Question 2: In the clinical treatment of rectal cancer, low and very low anus-preserving operations are becoming more and more mature. However, after removal of the internal anal sphincter, that is, after intersphincteric resection (IRS), the incidence of temporary fecal incontinence is very high. According to comprehensive literature data, the incidence rate within 3 months is 70-80%, but three The recovery rate after 1 month is 90%. This situation caused the patient to be in a state of fecal incontinence for several months after the operation, and even wearing diapers could not prevent odor and local contamination.
为了解决以上低位直肠切除的两个问题,目前的做法大多数是进行预防性结肠造瘘,但是该造瘘本身又有并发症,而且还需半年后再经历一次手术进行还纳,加大了患者的痛苦和负担。In order to solve the above two problems of low rectal resection, most of the current methods are preventive colostomy, but the colostomy itself has complications, and it will take half a year to undergo another operation for resection, which increases the cost. patient pain and burden.
用薄膜管道将粪便引流出肛门的思路可以解决上述问题,但是怎样将薄膜管道较长时间固定在特定的结肠部位,是一直难以克服的技术难点。结肠有以下特点:柔软、长时间压榨会导致糜烂穿孔、扩张性大、肌肉收缩性强、黏膜每隔两周左右就会脱离一层,这些导致现有支架在正常结肠难以使用。The idea of using a thin-film tube to drain the feces out of the anus can solve the above problems, but how to fix the thin-film tube on a specific colon site for a long time has always been a technical difficulty that has been difficult to overcome. The colon has the following characteristics: soft, long-term pressing will lead to erosion and perforation, large expansion, strong muscle contractility, and the mucosa will detach from a layer every two weeks or so, which makes it difficult to use the existing stents in the normal colon.
发明内容Contents of the invention
本发明的目的在于提供一种既能够较长时间固定薄膜管道,又不损伤肠管,且安全可靠,操作方便的肠道内旁路支架组件及其固定方法。The object of the present invention is to provide a intestinal bypass support assembly and a fixing method thereof which can fix the thin film pipeline for a long time without damaging the intestine, are safe, reliable, and easy to operate.
在本发明的第一方面,提供了一种肠道内旁路支架组件,具体地,包括支架和固定件;所述支架具有通孔和支架壁,所述支架壁包含第一突出部、第二突出部和固定部,所述固定部位于所述第一突出部和所述第二突出部之间;所述固定件为硬质环形结构;设所述第一突出部的外径和所述第二突出部的外径中的最小值为d1,所述固定部的外径为d2,所述固定件的内径为d3,则d1>d3>d2;使用时,所述支架位于肠道内,所述固定件套于肠道外并且卡套在所述支架的固定部对应的位置以固定肠道内的所述支架。In a first aspect of the present invention, an intestinal bypass bracket assembly is provided, specifically, including a bracket and a fixing member; the bracket has a through hole and a bracket wall, and the bracket wall includes a first protrusion, a second a protruding portion and a fixing portion, the fixing portion is located between the first protruding portion and the second protruding portion; the fixing member is a hard ring structure; the outer diameter of the first protruding portion and the The minimum value of the outer diameter of the second protruding part is d 1 , the outer diameter of the fixing part is d 2 , and the inner diameter of the fixing part is d 3 , then d 1 >d 3 >d 2 ; in use, the The stent is located in the intestinal tract, the fixing part is sleeved outside the intestinal tract and inserted into the position corresponding to the fixing part of the stent to fix the stent in the intestinal tract.
在另一优选例中,所述支架是一体的或多体组成的。In another preferred example, the stent is composed of one body or multiple bodies.
在另一优选例中,所述硬质环形结构由多个环形组件构成,各个环形组件的连接方式选自于卡扣连接、锁扣连接、螺纹连接、铰链连接、内嵌磁铁中的一种或者多种的组合;优选地,各个环形组件通过卡扣连接;更优选地,所述卡扣具有多个档级,通过调节所述档级调节所述固定件的直径大小。In another preferred example, the hard ring structure is composed of a plurality of ring components, and the connection mode of each ring component is selected from one of snap connection, lock connection, screw connection, hinge connection, and embedded magnet Or multiple combinations; preferably, each ring component is connected by a buckle; more preferably, the buckle has a plurality of grades, and the diameter of the fixing member is adjusted by adjusting the grades.
在另一优选例中,d3与d2之间的差值为3-20mm;优选地,为10-15mm。In another preferred example, the difference between d 3 and d 2 is 3-20 mm; preferably, 10-15 mm.
在另一优选例中,d3与d2之间的差值为肠壁厚度的1.0-4.0倍;优选地,是肠壁厚度的2.0-4.0倍;更佳地,是肠壁厚度的2.0-3.0倍。In another preferred example, the difference between d 3 and d 2 is 1.0-4.0 times the thickness of the intestinal wall; preferably, 2.0-4.0 times the thickness of the intestinal wall; more preferably, 2.0 times the thickness of the intestinal wall -3.0 times.
在另一优选例中,用于人直肠时,d3与d2之间的差值优选为10-15mm。In another preferred example, when used in human rectum, the difference between d 3 and d 2 is preferably 10-15mm.
在另一优选例中,所述肠道内旁路支架组件中的部分或者全部结构是由生物可降解材料制成的。In another preferred example, part or all of the structures in the intestinal bypass stent assembly are made of biodegradable materials.
在另一优选例中,所述生物可降解材料的降解周期是0.5-6个月。In another preferred example, the degradation period of the biodegradable material is 0.5-6 months.
在另一优选例中,所述支架和所述固定件的降解周期相近或相同。In another preferred example, the degradation periods of the bracket and the fixing member are similar or the same.
在另一优选例中,所述组件用于吻合位置较高的场合,不存在大便失禁问题,仅为隔离吻合口的大肠杆菌污染,所述固定件或者所述支架在肠道内的失效时间为2-3周。In another preferred example, the assembly is used in a high anastomotic position, there is no fecal incontinence problem, and it is only used to isolate the E. coli contamination of the anastomosis, and the failure time of the fixing member or the bracket in the intestinal tract is 2-3 weeks.
在另一优选例中,所述组件用于超低位吻合可能存在大便失禁问题的场合,其使用目的包含了隔离吻合口大肠杆菌污染和将肠道内容物引入粪袋,所述固定件或者所述支架在肠道内的失效时间为3-6个月。In another preferred example, the assembly is used in occasions where fecal incontinence may be caused by ultra-low anastomosis, and its purpose of use includes isolating E. The failure time of the stent in the intestinal tract is 3-6 months.
在另一优选例中,所述生物可降解材料选自于PLA、PGA、PDMA、PPDO、PCL、PTMC中的一种或者多种材料的共聚物,或上述材料的混合物。In another preferred embodiment, the biodegradable material is a copolymer of one or more materials selected from PLA, PGA, PDMA, PPDO, PCL, PTMC, or a mixture of the above materials.
在另一优选例中,所述固定件的内表面为外凸结构,并且所述外凸结构的形状与所述固定部的外表面的形状是相适应的。In another preferred example, the inner surface of the fixing part is a convex structure, and the shape of the convex structure is adapted to the shape of the outer surface of the fixing part.
在另一优选例中,所述固定件的高度为2-40mm;优选地,为3-30mm;更佳地,为4-10mm。In another preferred example, the height of the fixing member is 2-40mm; preferably, 3-30mm; more preferably, 4-10mm.
在另一优选例中,所述第一突出部和所述第二突出部之间设有多个所述固定部,并且每个所述固定部均设有与之相匹配的所述固定件。In another preferred example, a plurality of fixing parts are provided between the first protruding part and the second protruding part, and each of the fixing parts is provided with a corresponding fixing part .
在另一优选例中,相邻所述固定部之间具有隔断结构,所述隔断结构的外径大于所述固定部的外径。In another preferred example, there is a partition structure between adjacent fixed parts, and the outer diameter of the partition structure is larger than the outer diameter of the fixed part.
在本发明的第二方面提供了一种肠道内旁路装置,包含如权利要求1所述的肠道内旁路支架组件,其特征在于,还包括薄膜管道,所述薄膜管道的一端与所述支架连接并与所述支架的通孔贯通形成大肠内容物流出的通道(使大肠内容物与肠道吻合口隔离开)。The second aspect of the present invention provides an intestinal bypass device, comprising the intestinal bypass stent assembly as claimed in claim 1, characterized in that it also includes a thin film pipeline, one end of the thin film pipeline is connected to the The stent is connected and communicated with the through hole of the stent to form a passage for the contents of the large intestine to flow out (isolate the contents of the large intestine from the anastomosis of the intestinal tract).
在另一优选例中,所述薄膜管道的另一端延伸出肛门外并且与粪袋连接。In another preferred example, the other end of the film conduit extends out of the anus and is connected to the fecal bag.
在另一优选例中,所述薄膜管道为橡胶保护套;较佳地,所述橡胶保护套采用与避孕套相同的材质制成。In another preferred example, the thin film pipe is a rubber sheath; preferably, the rubber sheath is made of the same material as the condom.
在另一优选例中,所述薄膜管道的外壁还涂覆有抗菌成分。In another preferred example, the outer wall of the thin film duct is also coated with antibacterial components.
在本发明的第三方面提供了一种肠道内旁路支架组件的固定方法,包括以下步骤:In a third aspect of the present invention, a method for fixing an intestinal bypass stent assembly is provided, comprising the following steps:
a.提供肠道内旁路支架组件,所述肠道内旁路支架组件包括支架和固定件;所述支架具有通孔以及支架壁,所述支架壁包含第一突出部、第二突出部和固定部,所述固定部位于所述第一突出部和所述第二突出部之间;所述固定件为硬质环形结构;设所述第一突出部的外径和所述第二突出部的外径中的最小值为d1,所述固定部的外径为d2,所述硬质环形结构的内径为d3,则d1>d3>d2;a. Provide intestinal bypass bracket assembly, the intestinal bypass bracket assembly includes a bracket and a fixing piece; the bracket has a through hole and a bracket wall, the bracket wall includes a first protrusion, a second protrusion and a fixing part, the fixing part is located between the first protrusion and the second protrusion; the fixing part is a hard ring structure; the outer diameter of the first protrusion and the second protrusion are set The minimum value of the outer diameter is d 1 , the outer diameter of the fixing part is d 2 , and the inner diameter of the hard annular structure is d 3 , then d 1 >d 3 >d 2 ;
b.将所述支架置于肠道内部;b. placing the stent inside the intestinal tract;
c.将所述固定件套于肠道外并且卡套在所述支架的固定部对应的位置,以固定肠道内的所述支架。c. Put the fixing part outside the intestinal tract and insert it on the position corresponding to the fixing part of the bracket, so as to fix the bracket in the intestinal tract.
应理解,在本发明范围内中,本发明的上述各技术特征和在下文(如实施例)中具体描述的各技术特征之间都可以互相组合,从而构成新的或优选的技术方案。限于篇幅,在此不再一一累述。It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features specifically described in the following (such as embodiments) can be combined with each other to form new or preferred technical solutions. Due to space limitations, we will not repeat them here.
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图做简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的可替代的实施方式。In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the following will briefly introduce the drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only These are some embodiments of the present invention, and those skilled in the art can obtain other alternative implementations according to these drawings without creative efforts.
图1是本发明一个实施例中的肠道内旁路支架组件的侧视图;Fig. 1 is a side view of an intestinal bypass stent assembly in an embodiment of the present invention;
图2是图1所示肠道内旁路支架组件的A-A截面的剖视图;Fig. 2 is a cross-sectional view of the A-A section of the intestinal bypass stent assembly shown in Fig. 1;
图3是本发明一个实施例中的肠道内旁路支架组件的立体图;Fig. 3 is a perspective view of an intestinal bypass stent assembly in an embodiment of the present invention;
图4是图3所示肠道内旁路支架组件中的固定件的分解图;Fig. 4 is an exploded view of the fixing part in the intestinal bypass bracket assembly shown in Fig. 3;
图5是本发明的另一个实施例中的固定件的立体图;Fig. 5 is a perspective view of a fixing member in another embodiment of the present invention;
图6左是本发明一个实施例中的肠道内旁路支架组件固定于肠道的局部结构示意图;图6右是图6左的E-E截面的剖视图;The left side of Figure 6 is a schematic diagram of the local structure of the intestinal bypass bracket assembly fixed to the intestinal tract in an embodiment of the present invention; the right side of Figure 6 is a cross-sectional view of the E-E section on the left side of Figure 6;
图7左是本发明一个实施例中的具有多个固定部和隔断结构的肠道内旁路支架组件的结构示意图;图7右是图7左的F-F截面的剖视图;The left side of Fig. 7 is a structural schematic diagram of an intestinal bypass stent assembly with multiple fixing parts and partition structures in an embodiment of the present invention; the right side of Fig. 7 is a cross-sectional view of the F-F section on the left side of Fig. 7;
图8是低位直肠切除手术后不同方式固定支架对支架放置位置处肠壁的损伤情况的比较,a图中是采用可吸收线固定,b图中是采用编织带固定,c图中是采用胸普外科修补膜(市售产品)固定,d图是采用本发明一个实施例中的肠道内旁路支架组件;Figure 8 is a comparison of the damage to the intestinal wall at the position where the bracket is placed by different methods of fixing the bracket after low rectal resection. In figure a, absorbable thread is used for fixation, in figure b, braided band is used for fixation, and in figure c, breast tissue is used for fixation. General surgical mending membrane (commercially available product) is fixed, and figure d is to adopt the intestinal bypass stent assembly in an embodiment of the present invention;
图9是比格犬肠道吻合口处使用和未使用本发明旁路支架组件保护的直肠标本受大肠杆菌污染程度的三组对比试验图。Fig. 9 is three comparison test diagrams of the degree of Escherichia coli contamination of rectal specimens protected by the bypass stent assembly of the present invention at the anastomosis of the intestinal tract of Beagle dogs and without.
各附图中,各标示如下:In each attached drawing, each mark is as follows:
1-支架;11-通孔;111-通孔出口;12-支架壁;121-第一突出部;122-第二突出部;123-固定部;2-固定件;21-固定件内表面;3-薄膜管道;4-肠道;41-肠壁;5-吻合口;6-肛门;7-粪袋;8-肠道内容物;9-隔断结构;d1-第一突出部的外径和所述第二突出部的外径中的最小值;d2-固定部的外径;d3-固定件的内径;h-固定件的高度。1-bracket; 11-through hole; 111-through hole outlet; 12-bracket wall; 121-first protrusion; 122-second protrusion; 123-fixing part; 2-fixing part; 21-fixing part inner surface ;3-membrane duct; 4-intestine; 41-intestinal wall; 5-anastomosis; 6-anus; 7-fecal bag; 8-gut content; 9-partition structure; d 1 -of the first protrusion The minimum value of the outer diameter and the outer diameter of the second protrusion; d 2 - the outer diameter of the fixing part; d 3 - the inner diameter of the fixing part; h - the height of the fixing part.
具体实施方式Detailed ways
本发明人经过广泛而深入的研究,通过大量筛选,首次开发了一种肠道内旁路支架组件及其固定方法,与现有技术相比,本发明的关键之处在于保证完全隔离粪便的同时,提出硬质外固定件的理念,在内部支架和外固定件之间设置间隙,以达到既不压榨损伤肠管、又使肠道蠕动波顺利下传的效果。本发明开创了在结肠中隔离一段肠壁不被肠道内容物污染的可行方法,该方法也有可能推广至其他消化道。只要隔离时间足够长,一般的术后吻合口瘘都可以得到预防和治疗,在此基础上完成了本发明。After extensive and in-depth research and a large number of screenings, the inventor first developed an intestinal bypass bracket assembly and its fixing method. Compared with the prior art, the key point of the present invention is to ensure complete isolation of feces while , put forward the concept of hard external fixation, and set a gap between the internal bracket and the external fixation, so as to achieve the effect of not crushing and damaging the intestinal tube, but also allowing the intestinal peristaltic wave to pass down smoothly. The present invention pioneers a feasible method of isolating a section of intestinal wall in the colon from contamination by intestinal contents, and the method may also be extended to other digestive tracts. As long as the isolation time is long enough, general postoperative anastomotic leakage can be prevented and treated, and the present invention is completed on this basis.
术语the term
如本文所用,术语“硬质环形结构”是指该结构整体上是环形的并且是硬质的。所述的环形包括圆环、椭圆环、方环、无定形环等各种可能的环形;所述的硬质应当理解为具有一定的刚度以使得其结构或形状可以得到保持,通常情况下硬度大于邵氏A50度,优选地为邵氏A80度以上。这些等级的硬度可以用本领域公知的材料来实现。As used herein, the term "rigid annular structure" means that the structure is generally annular and rigid. The ring includes various possible rings such as circular ring, elliptical ring, square ring, and amorphous ring; the hard should be understood as having a certain rigidity so that its structure or shape can be maintained, usually the hardness Greater than 50 degrees of Shore A, preferably above 80 degrees of Shore A. These levels of hardness can be achieved with materials known in the art.
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外,附图为示意图,因此本发明装置和设备的并不受所述示意图的尺寸或比例限制。Below in conjunction with specific embodiment, further illustrate the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, the drawings are schematic diagrams, so the device and equipment of the present invention are not limited by the size or scale of the schematic diagrams.
需要说明的是,在本专利的权利要求和说明书中,诸如第一和第二等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。而且,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。在没有更多限制的情况下,由语句“包括一个”限定的要素,并不排除在包括所述要素的过程、方法、物品或者设备中还存在另外的相同要素。It should be noted that in the claims and description of this patent, relative terms such as first and second are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or Any such actual relationship or order between such entities or operations is implied. Furthermore, the term "comprises", "comprises" or any other variation thereof is intended to cover a non-exclusive inclusion such that a process, method, article or apparatus comprising a set of elements includes not only those elements, but also includes elements not expressly listed. other elements of or also include elements inherent in such a process, method, article, or apparatus. Without further limitations, an element defined by the statement "comprising a" does not exclude the presence of additional identical elements in the process, method, article or apparatus comprising said element.
实施例1Example 1
如图1-2所示,本实施例的肠道内旁路支架组件包括支架1和固定件2。该支架1包括通孔11和支架壁12,支架壁12包括第一突出部121、第二突出部122和固定部123,固定部123位于第一突出部121和第二突出部122之间,固定部为一中空管,突出部为喇叭口结构,该固定件2包括固定件内表面21,固定件2为硬质环形结构,固定件的高度为h。所述第一突出部121的外径和所述第二突出部122的外径中的最小值为d1,所述固定部的外径为d2,所述固定件的内径为d3,则d1>d3>d2。As shown in FIGS. 1-2 , the intestinal bypass stent assembly of this embodiment includes a stent 1 and a fixing member 2 . The bracket 1 includes a through hole 11 and a bracket wall 12, the bracket wall 12 includes a first protruding portion 121, a second protruding portion 122 and a fixing portion 123, the fixing portion 123 is located between the first protruding portion 121 and the second protruding portion 122, The fixing part is a hollow tube, and the protruding part is a bell mouth structure. The fixing part 2 includes the inner surface 21 of the fixing part. The fixing part 2 is a hard ring structure, and the height of the fixing part is h. The minimum value of the outer diameter of the first protruding portion 121 and the outer diameter of the second protruding portion 122 is d 1 , the outer diameter of the fixing portion is d 2 , the inner diameter of the fixing member is d 3 , Then d 1 >d 3 >d 2 .
所述突出部的外径指的是位于突出部外表面上且位于垂直于通孔11轴线的同一平面上的两点之间的最大距离;固定部的外径指的是位于固定部外表面上且位于垂直于通孔11轴线的同一平面上的两点之间的最大距离;固定件的内径指的是当固定件环套在支架固定部上并且固定件上表面与通孔11的轴线垂直时,位于固定件内表面上且位于垂直于通孔11轴线的同一平面上的两点之间的最大距离。The outer diameter of the protrusion refers to the maximum distance between two points located on the outer surface of the protrusion and on the same plane perpendicular to the axis of the through hole 11; The maximum distance between two points on the same plane perpendicular to the axis of the through hole 11; the inner diameter of the fixing part refers to when the fixing part is looped on the bracket fixing part and the upper surface of the fixing part and the axis of the through hole 11 When vertical, the maximum distance between two points on the inner surface of the fixing member and on the same plane perpendicular to the axis of the through hole 11.
所述固定件2的内表面与所述固定部123外表面之间间隙为(d3-d2)/2,所述间隙是指当固定件2环套在固定部123上并且固定件与固定部的中心重合时,固定件的内表面与靠近所述固定件的内表面的固定部的外表面之间的距离。The gap between the inner surface of the fixing part 2 and the outer surface of the fixing part 123 is ( d3 - d2 )/2, and the gap means that when the fixing part 2 is looped on the fixing part 123 and the fixing part and the fixing part When the centers of the fixing parts coincide, the distance between the inner surface of the fixing part and the outer surface of the fixing part close to the inner surface of the fixing part.
所述d3与d2之间的差值为:6-20mm;优选地,10-15mm。The difference between d 3 and d 2 is: 6-20mm; preferably, 10-15mm.
依据上述d3与d2之间的差值,我们推算当本旁路支架组件用到人体上时,d3与d2之间的差值为肠壁厚度的1.0-4.0倍;优选地,是肠壁厚度的2.0-4.0倍;较佳地,是肠壁厚度的2.0-3.0倍。肠壁厚度大约在3-7mm,特别是人直肠段一般在5mm左右,针对这一肠壁厚度,我们经过摸索认为d3与d2之间的差值设置为10-15mm的情况下本发明旁路支架组件可以达到最好的效果。According to the above difference between d 3 and d 2 , we estimate that when the bypass stent assembly is used on the human body, the difference between d 3 and d 2 is 1.0-4.0 times the thickness of the intestinal wall; preferably, It is 2.0-4.0 times the thickness of the intestinal wall; preferably, it is 2.0-3.0 times the thickness of the intestinal wall. The thickness of the intestinal wall is about 3-7mm, especially the human rectal section is generally about 5mm. In view of this thickness of the intestinal wall, we think through exploration that the difference between d 3 and d 2 is set to 10-15mm. The bypass bracket assembly works best.
在另一优选例中,所述支架是一体的或多体组成的。在另一优选例中,所述肠道内旁路支架组件中的部分或者全部结构是由生物可降解材料制成的,由此可以使得固定支架在吻合口愈合后通过降解失效,并排出体外。优选的情况下,所述肠道内旁路支架组件中的固定件全部是由生物可降解材料制成的;而所述肠道内旁路支架组件中的支架可以是由非生物可降解材料制成的,或者所述支架可以部分是或者全部是由生物可降解材料制成的。不论如何,本发明所强调的是通过生物降解可以使得肠道内旁路支架组件的固定作用失效以排出体外。In another preferred example, the stent is composed of one body or multiple bodies. In another preferred example, part or all of the structure of the intestinal bypass stent assembly is made of biodegradable materials, so that the fixed stent can be degraded and degraded after the anastomotic stoma is healed, and can be excreted from the body. Preferably, all the fixing parts in the intestinal bypass stent assembly are made of biodegradable materials; and the brackets in the intestinal bypass stent assembly can be made of non-biodegradable materials , or the stent may be partially or entirely made of biodegradable materials. In any case, the emphasis of the present invention is that the fixation of the bypass stent assembly in the intestinal tract can be invalidated through biodegradation so as to be excreted from the body.
在另一优选例中,所述生物可降解材料选自于PLA、PGA、PDMA、PPDO、PCL、PTMC中的一种或者多种材料的共聚物,或上述材料的混合物。In another preferred embodiment, the biodegradable material is a copolymer of one or more materials selected from PLA, PGA, PDMA, PPDO, PCL, PTMC, or a mixture of the above materials.
在另一优选例中,所述生物可降解材料的降解周期是0.5-6个月。In another preferred example, the degradation period of the biodegradable material is 0.5-6 months.
在另一优选例中,所述支架1和所述固定件2的降解周期相近或相同。In another preferred example, the degradation periods of the stent 1 and the fixing member 2 are similar or the same.
需要说明的是本发明所述的支架并非只能采用附图中所示的结构,还可以采用多种不同的结构类型。在一优选例中所述支架在具有本发明权利要求所示特点(具有通孔和支架壁,所述支架壁包含第一突出部、第二突出部和固定部,所述固定部位于所述第一突出部和所述第二突出部之间)的前提下,可以是任何可能的结构,例如Valtrac吻合环等环状的支架,也可以是由充气球囊构成的支架结构,也可以是网状支架。在最优的情况下,所述支架也采用硬质结构。It should be noted that the stent of the present invention can not only adopt the structure shown in the drawings, but also can adopt many different types of structures. In a preferred example, the bracket has the characteristics shown in the claims of the present invention (has a through hole and a bracket wall, and the bracket wall includes a first protrusion, a second protrusion and a fixing part, and the fixing part is located at the Between the first protruding portion and the second protruding portion) under the premise, it can be any possible structure, such as ring-shaped stents such as Valtrac anastomotic rings, it can also be a stent structure made of inflatable balloons, or it can be Mesh stand. In optimal cases, the bracket is also of rigid construction.
实施例2Example 2
如图3-5所示,本实施例的肠道内旁路支架组件包括支架1和固定件2。该支架1包括通孔11和支架壁12,通孔11包括通孔出口111,支架壁12包括第一突出部121、第二突出部122和固定部123,固定部123位于第一突出部121和第二突出部122之间,该固定件2该固定件2包括固定件内表面21,环形组件22,固定件2为硬质环形结构。As shown in FIGS. 3-5 , the intestinal bypass stent assembly of this embodiment includes a stent 1 and a fixing member 2 . The bracket 1 includes a through hole 11 and a bracket wall 12, the through hole 11 includes a through hole outlet 111, the bracket wall 12 includes a first protruding portion 121, a second protruding portion 122 and a fixing portion 123, the fixing portion 123 is located at the first protruding portion 121 Between the second protruding part 122 , the fixing part 2 includes a fixing part inner surface 21 and a ring component 22 , and the fixing part 2 is a hard ring structure.
所述第一突出部121的外径和所述第二突出部122的外径中的最小值为d1,所述固定部的外径为d2,所述固定件的内径为d3,则d1>d3>d2;The minimum value of the outer diameter of the first protruding portion 121 and the outer diameter of the second protruding portion 122 is d 1 , the outer diameter of the fixing portion is d 2 , the inner diameter of the fixing member is d 3 , Then d 1 >d 3 >d 2 ;
在另一优选例中,所述硬质环形结构2由多个环形组件22,多个环形组件22的连接方式选自于卡扣连接、锁扣连接、螺纹连接、铰链连接、内嵌磁铁中的一种或者多种的组合。图4和图5显示了根据本发明的两种不同的固定环的结构,固定环由两个半圆环构成,两个半圆环通过卡扣连接。优选地,该卡扣结构还可以具有多个档级,通过调节所述档级调节所述固定件的内大小。In another preferred example, the hard ring structure 2 is composed of a plurality of ring components 22, and the connection mode of the plurality of ring components 22 is selected from snap connection, lock connection, screw connection, hinge connection, and embedded magnet. one or a combination of more. Fig. 4 and Fig. 5 show the structure of two different fixing rings according to the present invention, the fixing ring is composed of two semi-circular rings, and the two semi-circular rings are connected by buckling. Preferably, the buckle structure can also have a plurality of steps, and the inner size of the fixing member can be adjusted by adjusting the steps.
在另一优选例中,所述硬质环形结构2为具有开口的环形结构,开口的尺寸小与支架固定部的外径大小。In another preferred example, the hard ring structure 2 is a ring structure with an opening, and the size of the opening is as small as the outer diameter of the bracket fixing part.
在另一优选例中,所述固定件的内表面为外凸结构,并且所述外凸结构的形状与所述固定部的外表面的形状是相适形应的,以减少对肠壁的挤压。In another preferred example, the inner surface of the fixing member is a convex structure, and the shape of the convex structure is adapted to the shape of the outer surface of the fixing part, so as to reduce the impact on the intestinal wall. extrusion.
在另一优选例中,为减少对肠壁的挤压力,可增加固定件和肠壁的接触面积,例如将所述固定件制成有一定高度的硬质环形结构可达到该效果,优选地所述固定件的高度h为2-40mm;更优选地,为3-30mm;更佳地,为4-10mm。In another preferred example, in order to reduce the extrusion force on the intestinal wall, the contact area between the fixing piece and the intestinal wall can be increased, for example, the fixing piece can be made into a hard ring structure with a certain height to achieve this effect, preferably Specifically, the height h of the fixing member is 2-40mm; more preferably, 3-30mm; more preferably, 4-10mm.
在另一优选例中,环形组件22的连接部位两侧具有凹槽。In another preferred example, there are grooves on both sides of the connecting portion of the ring component 22 .
实施例3Example 3
如图6所示,实施例3的肠道内旁路支架组件与实施例1或2类似,与之不同的是实施例3的支架组件还包括薄膜管道3,所述薄膜管道3的一端与所述支架1的一端连接并与所述支架1的通孔11贯通形成肠道4内容物流通的通道,使肠道内容物8与肠道吻合口6隔离开。As shown in Figure 6, the intestinal bypass stent assembly of embodiment 3 is similar to embodiment 1 or 2, the difference is that the stent assembly of embodiment 3 also includes a thin film duct 3, and one end of the thin film duct 3 is connected to the One end of the stent 1 is connected and connected with the through hole 11 of the stent 1 to form a passage for the contents of the intestinal tract 4 to isolate the contents of the intestinal tract 8 from the anastomotic opening 6 of the intestinal tract.
在另一优选例中,所述支架组件用于吻合位置较高的场合,不存在大便失禁问题,仅为隔离吻合口的大肠杆菌污染,所述固定件2或者所述支架1在肠道内的失效时间为2-3周。In another preferred example, the stent assembly is used in a place where the anastomotic position is high, there is no problem of fecal incontinence, and it is only used to isolate the E. coli contamination of the anastomosis. Expiration time is 2-3 weeks.
在另一优选例中,所述支架1是用于超低位吻合口可能存在大便失禁问题的场合;优选地,所述支架组件还包括粪袋7,所述粪袋7与所述薄膜管道3的延伸出肛门外的一端连接,本实施例支架组件使用目的包含了隔离吻合口6大肠杆菌污染和将肠道内容物引入粪袋7,固定件2在腹腔内失效时间为3-6个月左右,支架1在肠道内的失效时间也为3-6个月。In another preferred example, the stent 1 is used in occasions where fecal incontinence problems may exist at an ultra-low anastomotic stoma; The end extending out of the anus is connected. The purpose of the bracket assembly in this embodiment includes isolating the E. coli contamination of the anastomosis 6 and introducing the intestinal contents into the fecal bag 7. The failure time of the fixing part 2 in the abdominal cavity is 3-6 months The failure time of the stent 1 in the intestinal tract is also 3-6 months.
在另一优选例中,所述薄膜管道3为橡胶保护套;较佳地,所述橡胶保护套采用与避孕套相同的材质制成。In another preferred example, the membrane pipe 3 is a rubber sheath; preferably, the rubber sheath is made of the same material as a condom.
在另一优选例中,所述薄膜管道3的外壁还涂覆有抗菌成分,特别优选地是涂覆有缓释抗菌药物,如此可以有效抑制薄膜管道所保护的肠壁段细菌滋生,以防止吻合口感染。In another preferred example, the outer wall of the thin film pipeline 3 is also coated with antibacterial ingredients, especially preferably coated with slow-release antibacterial drugs, so that the growth of bacteria in the intestinal wall section protected by the thin film pipeline can be effectively inhibited to prevent Anastomotic infection.
实施例4Example 4
本实施例提供一种将本发明旁路支架组件的固定方法,所述方法包括以下步骤:This embodiment provides a method for fixing the bypass bracket assembly of the present invention, and the method includes the following steps:
a.提供一如实施例3所述的旁路支架组件;a. provide a bypass bracket assembly as described in embodiment 3;
b.将所述橡胶保护套的一端与所述支架1连接,然后使用置入工具将所述支架1和橡胶保护套置于肠道4内部,橡胶保护套另一端覆盖吻合口并伸出肛门;b. Connect one end of the rubber sheath to the stent 1, and then place the stent 1 and the rubber sheath inside the intestinal tract 4 using an insertion tool, and the other end of the rubber sheath covers the anastomosis and extends out of the anus ;
c.将所述硬质环形结构固定件2套于肠道4外并且卡套在所述支架1的固定部对应的位置,使置入肠道内的支架与肠道固定在一起。c. Put the rigid annular structural fixing member 2 outside the intestinal tract 4 and clamp it at the position corresponding to the fixing part of the stent 1, so that the stent inserted into the intestinal tract is fixed with the intestinal tract.
在另一优选例中,橡胶保护套伸出肛门的一端与粪袋连接。In another preferred example, one end of the rubber protective sheath protruding from the anus is connected with the fecal bag.
实施例5Example 5
如图7所示,实施例5的肠道内旁路支架组件与实施例1或2类似,与之不同的是:实施例5的支架组件包括多个固定部,其中,多个固定部位于第一突出部和第二突出部之间,且相邻固定部之间具有隔断结构9,隔断结构9的外径与突出部外径相近或相同,每个固定部有与之相匹配的固定件2。As shown in Figure 7, the intestinal bypass stent assembly of Example 5 is similar to that of Example 1 or 2, the difference is that the stent assembly of Example 5 includes a plurality of fixing parts, wherein the plurality of fixing parts are located at the first There is a partition structure 9 between the first protruding part and the second protruding part, and between adjacent fixed parts. The outer diameter of the partition structure 9 is similar to or the same as the outer diameter of the protruding part, and each fixed part has a corresponding fixing piece 2.
实施例6Example 6
本实施例将四种旁路装置在比格犬上做了对比试验,四种旁路装置如下,第一组:由可降解吻合环(Valtrac环状的支架)、可吸收线(薇乔线)、橡胶保护套构成的旁路装置;第二组:由可降解吻合环(Valtrac环状的支架)、可吸收编织带、橡胶保护套构成的旁路装置;第三组:由可降解吻合环(Valtrac环状的支架)、胸普外科修补膜(市售产品)、橡胶保护套构成的旁路装置;第四组:本发明实施例3的旁路装置,此实施例中d3-d2的差值为10mm(即固定件2与支架1的间隙为5mm)。In this embodiment, four kinds of bypass devices are tested on Beagle dogs. The four kinds of bypass devices are as follows. ), a bypass device composed of a rubber protective sleeve; the second group: a bypass device composed of a degradable anastomotic ring (Valtrac annular bracket), an absorbable braid, and a rubber protective sleeve; the third group: a biodegradable anastomotic A bypass device composed of a ring (Valtrac ring-shaped bracket), thoracic surgery repair membrane (commercially available product), and a rubber sheath; the fourth group: the bypass device of Embodiment 3 of the present invention, in this embodiment d 3 - The difference between d and 2 is 10mm (that is, the gap between the fixing part 2 and the bracket 1 is 5mm).
试验方法如下:The test method is as follows:
首先选用4只实验用比格犬(标号为1、2、3、4),实验前30分钟将西力欣2.0g静注到4只比格犬体内,以预防感染,然后将比格犬后腿静脉穿刺静注3%戊巴比妥钠1ml/kg。待4只犬完全麻醉后于左下腹及背部剃毛备皮,背部安放高频电刀负极板,常规于左下腹消毒,铺巾;左下腹旁正中切口,长约8cm。依次打开皮肤、皮下组织、脂肪,钝性分离肌肉层,打开腹膜。于腹腔内找到下段降结肠。First select 4 experimental Beagle dogs (labeled as 1, 2, 3, 4), inject Xilixin 2.0g into the 4 Beagle dogs 30 minutes before the experiment to prevent infection, and then inject the Beagle dogs Intravenous injection of 3% pentobarbital sodium 1ml/kg by venipuncture of hind legs. After the 4 dogs were fully anesthetized, the left lower abdomen and back were shaved and the skin was prepared. A high-frequency electric knife negative plate was placed on the back. The left lower abdomen was routinely disinfected and a towel was laid. A midline incision was made on the left lower abdomen, about 8 cm long. The skin, subcutaneous tissue, and fat are opened in sequence, the muscle layer is bluntly separated, and the peritoneum is opened. Locate the lower descending colon in the abdominal cavity.
然后将橡胶保护套的一端与可降解吻合环固定连接,作为肠道内容物流通的通道,将第一种旁路装置的可降解吻合环自肛门以石蜡油润滑后置入1号比格犬肠道内,橡胶保护套的另一端伸出肛门,用1-0薇乔线在肠壁外环形结扎,注意松紧合适,以固定保护环于下段结肠;其余三组实验方法同上,唯独肠道外固定方法不同。Then one end of the rubber protective sheath was fixedly connected with the biodegradable anastomotic ring as a channel for the flow of intestinal contents, and the degradable anastomotic ring of the first bypass device was lubricated with paraffin oil from the anus and inserted into the No. 1 Beagle dog In the intestinal tract, the other end of the rubber protective sleeve protrudes from the anus, and a 1-0 Vicryl line is used to loop the outer intestinal wall, paying attention to the tightness, so as to fix the protective ring on the lower colon; the other three experimental methods are the same as above, except that the outer intestinal Fixing methods are different.
最后用7#慕丝线关闭腹膜与腹直肌前后鞘,以4#慕丝线关闭皮下组织与皮肤。切口再次消毒后,术毕将4只比格犬送回动物房苏醒。Finally, close the peritoneum and rectus sheath with 7# mousse thread, and close the subcutaneous tissue and skin with 4# mousse thread. After the incision was disinfected again, the 4 Beagle dogs were sent back to the animal room to wake up after the operation.
让上述四组肠道内旁路装置在比格犬体内停留21天,期间戴脖圈防止狗咬坏肛门外橡胶保护套。麻药过量安乐死法处死4只比格犬,观察结肠壁损伤情况。获得的四组结肠样本如图8所示(a图为第一种旁路装置固定时和解剖后的结肠样本,b图为第二组旁路装置固定时和解剖后的结肠样本,c图为第三组旁路装置固定时和解剖后的结肠样本,d图为本装置固定时和解剖后的结肠标本):a图显示薇乔线切割肠壁,吻合环放置部位有一明显的裂痕,肠黏膜皱襞中断;b图和c图显示固定带导致肠壁有局部溃疡穿孔;d图显示硬质环形结构固定件放置部位没有肉眼可见的明显的损伤。Let the above-mentioned four groups of intestinal bypass devices stay in the Beagle dog for 21 days, and wear a collar during the period to prevent the dog from biting the rubber protective sleeve outside the anus. Four Beagle dogs were euthanized by anesthesia overdose, and the damage of the colon wall was observed. The obtained four groups of colon samples are shown in Figure 8 (a is the colon sample when the first bypass device is fixed and dissected, b is the second group of colon samples when the bypass device is fixed and dissected, and c is the colon sample The third group of colon samples when the bypass device was fixed and dissected, and picture d shows the colon samples when this device was fixed and after dissection): picture a shows that the intestinal wall was cut by Vicryl wire, and there was an obvious crack at the place where the anastomotic ring was placed, The folds of the intestinal mucosa were interrupted; pictures b and c showed local ulcer perforation of the intestinal wall caused by the fixation tape; picture d showed that there was no obvious damage visible to the naked eye at the place where the rigid ring structure was placed.
经动物实验证实,可吸收线、可吸收编织带和生物补片等软质的可生物吸收材料对结肠内支架进行固定,尽管在试验中已经非常精细地保持适当捆扎的紧张度,但用这些方法固定会发生固定位置肠壁的穿孔或损伤;本发明肠道内旁路支架组件可以在不损伤肠壁的情况下,固定结直肠内的中空支架性结构(即支架1)。It has been confirmed by animal experiments that soft bioabsorbable materials such as absorbable threads, absorbable braids, and bio-patch are used to fix colonic stents. Methods Fixation will cause perforation or damage to the intestinal wall at a fixed position; the intestinal bypass stent assembly of the present invention can fix the hollow stent structure (ie, stent 1) in the colorectum without damaging the intestinal wall.
实施例7Example 7
本发明通过在比格犬身上做试验,证明了硬质结构的外固定环和内支架相结合不会对肠壁产生损伤切割作用,但是此装置是否真的可以起到保护吻合口不受污染的作用呢?The present invention proves that the combination of the outer fixation ring and the inner bracket of the hard structure will not damage and cut the intestinal wall through experiments on Beagle dogs, but whether this device can really protect the anastomotic stoma from pollution What about the role?
为此发明人做了这样的试验:观察肠道被保护部分,黏膜表面的大肠杆菌是否有明显减少。For this reason, the inventor has done such a test: observe whether the Escherichia coli on the surface of the mucous membrane is significantly reduced in the protected part of the intestinal tract.
试验方法:experiment method:
收取比格犬肠道吻合口处使用和未使用本发明旁路支架组件保护的直肠标本。如同实施例6的实验方法,使用本发明装置,此实施例中d3-d2的差值为15mm(即固定件2与支架1的间隙为7.5mm)。手术结束时像人体直肠切除手术后肠道消毒方法一样,经肛门在橡胶保护套外(即保护套与直结肠黏膜之间)注入Ⅲ型安尔碘100ml,共三次。到21天解剖观察肠壁情况后,首先用6个无菌器皿取样本,分成三组进行对比,每组一个无菌器皿中是本装置下段被保护的直肠标本,另一个无菌器皿中是本装置上方未保护的直肠标本,观察每组2个无菌器皿中的大肠杆菌数量;每个样本不冲洗,用电子秤称量,每组样本内黏膜重量要一致,放入5ml无菌玻璃匀浆器中每10mg组织加入1ml生理盐水,制备成肠壁匀浆母液待用。另制备无菌琼脂糖大肠杆菌培养基,在9cm培养皿中加入20ml培养基以及稀释100倍的肠壁匀浆液1ml,在37℃条件下培养箱培养24小时,肉眼观察培养皿中菌落数。三组结果见图9(图左边为未使用本发明旁路支架组件保护的情况下无菌器皿中的大肠杆菌数量和图右边为使用本发明旁路支架组件保护的情况下无菌器皿中的大肠杆菌数量)。The rectal specimens that were used or not protected by the bypass stent assembly of the present invention were collected from the intestinal anastomosis of Beagle dogs. Similar to the experimental method in Example 6, using the device of the present invention, the difference between d 3 -d 2 in this example is 15 mm (that is, the gap between the fixing member 2 and the bracket 1 is 7.5 mm). At the end of the operation, 100ml of type III Amer iodine was injected through the anus outside the rubber protective sheath (between the protective sheath and the rectal mucosa) for a total of three times in the same way as the intestinal disinfection method after rectal resection. After dissecting and observing the condition of the intestinal wall on day 21, firstly use 6 sterile containers to take samples and divide them into three groups for comparison. One sterile container in each group is the rectal specimen protected by the lower part of the device, and the other sterile container is For the unprotected rectal specimen above the device, observe the number of E. coli in 2 sterile containers in each group; each sample is not rinsed, and weighed with an electronic scale. The weight of the mucous membrane in each group of samples must be consistent, and put 5ml of sterile glass Add 1ml of physiological saline to every 10mg of tissue in the homogenizer to prepare the intestinal wall homogenate mother solution for use. Separately prepare sterile agarose E. coli culture medium, add 20ml of culture medium and 1ml of intestinal wall homogenate diluted 100 times to a 9cm petri dish, incubate in an incubator at 37°C for 24 hours, and observe the number of colonies in the petri dish with naked eyes. The three groups of results are shown in Fig. 9 (the left side of the figure is the number of Escherichia coli in the aseptic vessel under the protection situation of the bypass support assembly of the present invention and the Escherichia coli number in the sterile vessel under the protection of the bypass support assembly of the present invention is used on the right side of the figure. coli count).
结果显示应用本发明肠道内旁路装置,肠道被保护部分黏膜表面的大肠杆菌减少到可以忽略不计的程度。经试验证实:在本发明旁路支架组件保护的肠道被保护部分,黏膜表面不再受大肠杆菌沾染。The results show that the Escherichia coli on the mucosal surface of the protected part of the intestinal tract is reduced to a negligible level by using the intestinal bypass device of the present invention. It has been proved by experiments that in the protected part of the intestinal tract protected by the bypass stent assembly of the present invention, the mucosal surface is no longer contaminated by Escherichia coli.
讨论discuss
针对结肠内支架难以固定的难题,本发明人先后用可吸收线、可吸收线编织固定带、生物补片结构的固定带等软质的可生物吸收材料对结肠内支架进行固定,尽管在所有的试验中已经非常精细地保持适当捆扎的紧张度,用这些方法固定均发生了固定位置肠壁的穿孔或损伤。分析原因如下:肠管内软性支架不能停留,需要肠管内硬性支架;结肠会不断对硬性支架产生推压,有较强的肌肉收缩发生。由于外固定装置是软性结构,肌肉收缩时外固定装置对肠壁的挤压力量容易集中在一点,长期就造成了肠壁被切割损失。Aiming at the problem that the stent in the colon is difficult to fix, the inventors successively fixed the stent in the colon with soft bioabsorbable materials such as absorbable threads, absorbable thread braided fixation belts, and fixation belts with biological patch structures. The tension of the proper bandage has been maintained very carefully in the experiments in the 1990s, and the perforation or injury of the intestinal wall at the fixed position occurred with these methods of fixation. The reasons are as follows: the soft stent in the intestine cannot stay, and a rigid stent in the intestine is required; the colon will constantly push the rigid stent, and strong muscle contraction occurs. Since the external fixation device is a soft structure, the extrusion force of the external fixation device on the intestinal wall is easy to concentrate on one point during muscle contraction, which will cause the intestinal wall to be cut and lost in the long run.
最终,本发明人根据肠壁运动的特点,首次提出了新的解决方案:若要将薄膜套管固定在肠内,就要由肠壁外固定装置和肠管内支架共同完成。在此基础上,本发明人设计了具有特定结构的肠道内旁路支架组件,包括支架和固定件,固定件采用硬质环形结构,并采用了特定的固定件与肠管内支架之间的间隙。Finally, the inventors proposed a new solution for the first time based on the characteristics of intestinal wall movement: if the film sleeve is to be fixed in the intestine, it must be completed by an external fixation device on the intestinal wall and an intestinal stent. On this basis, the inventors designed an intestinal bypass stent assembly with a specific structure, including a stent and a fixation piece, the fixation piece adopts a hard ring structure, and a specific gap between the fixation piece and the intestinal stent is adopted .
经动物实验证实,本发明肠道内旁路支架组件可以在不损伤肠壁的情况下,固定结直肠内的中空支架性结构(即支架),同时使得大肠杆菌不从支架外渗漏入下端肠管黏膜表面。具体机制是硬质的外固定环可以在肌肉收缩时将力量分散在环的其他部位,也会在内固定支架狭窄部位做一定的上下移动,允许蠕动波传递过外固定环和内固定支架的间隙。Animal experiments have confirmed that the intestinal bypass stent assembly of the present invention can fix the hollow stent structure (i.e. stent) in the colorectum without damaging the intestinal wall, and at the same time prevent Escherichia coli from leaking from the stent into the lower intestine mucosal surface. The specific mechanism is that the hard external fixation ring can disperse the force to other parts of the ring when the muscle contracts, and it will also move up and down to a certain extent in the narrow part of the internal fixation bracket, allowing peristaltic waves to pass through the external fixation ring and the internal fixation bracket. gap.
在现有技术中,一种技术是依靠三个环形的充气或其他材料的内支架来达到隔离粪便不沾染下段肠壁的功能。结肠的肠壁肌肉分为内环肌和外纵肌,其中外纵肌比结肠浆膜纵行短,因而形成“结肠袋”,这使结肠有较大的扩张性,扩张性支架难以停留,因此效果难以令人满意。同样,当结肠袋扩张时内支架也难以隔离肠内容物不进入下端肠壁。因此,与本发明隔离粪便依靠的是内支架与外固定环之间的间隙配合相比,该现有技术的隔离部位和隔离原理不同。In the prior art, one technique is to rely on three ring-shaped inner stents of inflatable or other materials to achieve the function of isolating feces from contaminating the lower intestinal wall. The intestinal wall muscles of the colon are divided into the inner circular muscle and the outer longitudinal muscle. The outer longitudinal muscle is shorter than the colon serosa longitudinally, thus forming a "colon bag", which makes the colon more expandable, and it is difficult for the expandable stent to stay. Therefore, the effect is unsatisfactory. Likewise, internal stents have difficulty in isolating bowel contents from the lower bowel wall when the colonic pouch expands. Therefore, compared with the separation of feces in the present invention, which relies on the clearance fit between the inner bracket and the outer fixing ring, the isolation position and isolation principle of the prior art are different.
另一种技术是采用吻合环作为固定保护套的工具。然而,在该技术中,吻合环必须进行扣紧,相当于做了一次吻合口上方肠管的二次吻合。基于已报道的采用吻合环进行肠管吻合的资料,大样本临床观察研究见于2000年,共有244例肠道吻合患者,119例为小肠-结肠吻合,125例为结肠-结肠端端吻合,共有16位患者发生吻合相关并发症:一个为狭窄进行再手术,15例(6.15%)为吻合口裂开,其中12例再手术,得出的结论是吻合环与钉合式吻合器的并发症发生率相当。主要原因可能是:用吻合环在低位直肠吻合口上方又进行一次肠管吻合,其本身吻合口瘘的发生率与管状吻合器相当,并不能减少整体吻合口瘘的发生率。Another technique is to use an anastomotic ring as a means of securing the sheath. However, in this technique, the anastomotic ring must be fastened, which is equivalent to doing a second anastomosis of the bowel above the anastomosis. Based on the reported data of bowel anastomosis using anastomotic rings, a large-scale clinical observational study was found in 2000. There were 244 patients with intestinal anastomosis, 119 cases of small bowel-colon anastomosis, and 125 cases of colon-colon end-to-end anastomosis. Anastomosis-related complications occurred in 2 patients: one reoperation for stenosis, 15 cases (6.15%) for anastomotic dehiscence, of which 12 cases were reoperation, the conclusion is that the complication rate of anastomotic ring and stapled stapler quite. The main reason may be that using an anastomotic ring to perform another intestinal anastomosis above the low rectal anastomosis has the same incidence of anastomotic leakage as the tubular stapler, and cannot reduce the overall incidence of anastomotic leakage.
本发明的重点在于,首次意外地发现,采用本发明所述结构的安全固定肠内支架(或相应装置),不仅不会损伤肠壁,而且可极其有效地封闭隔离粪便。The key point of the present invention is that it is unexpectedly found for the first time that the safe fixed intestinal stent (or corresponding device) adopting the structure of the present invention not only does not damage the intestinal wall, but also can seal and isolate feces extremely effectively.
本发明人多年的动物试验还证明,采用线状的外固定装置时,会在很短时间(7-14天)切割进入肠管;采用软质外固定装置(包括可吸收带、牛心包补片)时,仍有可能在某一点上形成肠壁穿孔。The inventor's many years of animal experiments have also proved that when using a linear external fixation device, it will cut into the intestine in a very short period of time (7-14 days); ), there is still the possibility of perforation of the bowel wall at some point.
与之相反,采用本发明的肠道内旁路支架组件时,由于采用的特定结构、特定材质和/或外固定环与内支架的匹配的特定间隙,出乎意料地实现了以下技术效果:既不压榨损伤肠管、使肠道蠕动波顺利下传,又有效隔离粪便不进入下段肠壁。On the contrary, when the intestinal bypass stent assembly of the present invention is adopted, the following technical effects are unexpectedly achieved due to the specific structure, specific material and/or matching specific gap between the outer fixing ring and the inner stent: It does not squeeze and damage the intestinal tube, so that the intestinal peristaltic wave can pass down smoothly, and effectively isolates the feces from entering the lower intestinal wall.
在本发明提及的所有文献都在本申请中引用作为参考,就如同每一篇文献被单独引用作为参考那样。此外应理解,在阅读了本发明的上述讲授内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。All documents mentioned in this application are incorporated by reference in this application as if each were individually incorporated by reference. In addition, it should be understood that after reading the above teaching content of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810134821.2A CN110123498A (en) | 2018-02-09 | 2018-02-09 | A kind of enteron aisle internal bypass bracket component and its fixing means |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810134821.2A CN110123498A (en) | 2018-02-09 | 2018-02-09 | A kind of enteron aisle internal bypass bracket component and its fixing means |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110123498A true CN110123498A (en) | 2019-08-16 |
Family
ID=67568012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810134821.2A Pending CN110123498A (en) | 2018-02-09 | 2018-02-09 | A kind of enteron aisle internal bypass bracket component and its fixing means |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110123498A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112826556A (en) * | 2021-03-04 | 2021-05-25 | 上海市同济医院 | Design of a long-term immobilization intraluminal device |
| CN114515176A (en) * | 2020-11-20 | 2022-05-20 | 天臣国际医疗科技股份有限公司 | anastomotic protection device |
| CN114515200A (en) * | 2020-11-20 | 2022-05-20 | 天臣国际医疗科技股份有限公司 | Magnetic particle-based anastomotic protection components |
| CN114515177A (en) * | 2020-11-20 | 2022-05-20 | 天臣国际医疗科技股份有限公司 | Anastomotic stoma protection device |
| CN114515178A (en) * | 2020-11-20 | 2022-05-20 | 天臣国际医疗科技股份有限公司 | Anastomotic stoma protection device |
| WO2022105854A1 (en) * | 2020-11-20 | 2022-05-27 | 天臣国际医疗科技股份有限公司 | Anastomotic stoma protection device |
| CN115700109A (en) * | 2021-07-30 | 2023-02-07 | 先健科技(深圳)有限公司 | Intestinal tract bracket and intestinal tract bracket assembly convenient to recover |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101264028A (en) * | 2008-04-14 | 2008-09-17 | 浙江大学 | Intestinal bypass device based on Valtrac anastomotic ring |
| CN201216623Y (en) * | 2008-05-09 | 2009-04-08 | 蔡秀军 | intestinal anastomosis stent |
| CN101969881A (en) * | 2007-11-08 | 2011-02-09 | 更新医药股份有限公司 | Fecal incontinence device, system and method |
| CN104382624A (en) * | 2014-07-24 | 2015-03-04 | 西安交通大学医学院第一附属医院 | Novel inner-intestinal-tract bypass device capable of being automatically discharged |
| WO2015084993A1 (en) * | 2013-12-06 | 2015-06-11 | W. L. Gore & Associates, Inc. | Anastomotic connectors |
| US20160058585A1 (en) * | 2014-08-29 | 2016-03-03 | Boston Scientific Scimed, Inc. | Medical devices including covers and methods for making and using same |
| CN105852917A (en) * | 2016-04-19 | 2016-08-17 | 杭州铭众生物科技有限公司 | A side mouthpiece for enterostomy |
-
2018
- 2018-02-09 CN CN201810134821.2A patent/CN110123498A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101969881A (en) * | 2007-11-08 | 2011-02-09 | 更新医药股份有限公司 | Fecal incontinence device, system and method |
| CN101264028A (en) * | 2008-04-14 | 2008-09-17 | 浙江大学 | Intestinal bypass device based on Valtrac anastomotic ring |
| CN201216623Y (en) * | 2008-05-09 | 2009-04-08 | 蔡秀军 | intestinal anastomosis stent |
| WO2015084993A1 (en) * | 2013-12-06 | 2015-06-11 | W. L. Gore & Associates, Inc. | Anastomotic connectors |
| CN104382624A (en) * | 2014-07-24 | 2015-03-04 | 西安交通大学医学院第一附属医院 | Novel inner-intestinal-tract bypass device capable of being automatically discharged |
| US20160058585A1 (en) * | 2014-08-29 | 2016-03-03 | Boston Scientific Scimed, Inc. | Medical devices including covers and methods for making and using same |
| CN105852917A (en) * | 2016-04-19 | 2016-08-17 | 杭州铭众生物科技有限公司 | A side mouthpiece for enterostomy |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114515176A (en) * | 2020-11-20 | 2022-05-20 | 天臣国际医疗科技股份有限公司 | anastomotic protection device |
| CN114515200A (en) * | 2020-11-20 | 2022-05-20 | 天臣国际医疗科技股份有限公司 | Magnetic particle-based anastomotic protection components |
| CN114515177A (en) * | 2020-11-20 | 2022-05-20 | 天臣国际医疗科技股份有限公司 | Anastomotic stoma protection device |
| CN114515178A (en) * | 2020-11-20 | 2022-05-20 | 天臣国际医疗科技股份有限公司 | Anastomotic stoma protection device |
| WO2022105854A1 (en) * | 2020-11-20 | 2022-05-27 | 天臣国际医疗科技股份有限公司 | Anastomotic stoma protection device |
| CN114515177B (en) * | 2020-11-20 | 2024-05-28 | 天臣国际医疗科技股份有限公司 | Anastomotic protection device |
| CN114515178B (en) * | 2020-11-20 | 2024-06-11 | 天臣国际医疗科技股份有限公司 | Anastomotic stoma protection device |
| CN112826556A (en) * | 2021-03-04 | 2021-05-25 | 上海市同济医院 | Design of a long-term immobilization intraluminal device |
| CN115700109A (en) * | 2021-07-30 | 2023-02-07 | 先健科技(深圳)有限公司 | Intestinal tract bracket and intestinal tract bracket assembly convenient to recover |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110123498A (en) | A kind of enteron aisle internal bypass bracket component and its fixing means | |
| EP3785679B1 (en) | A degradable intestinal diversion device | |
| CN103841929B (en) | Negative pressure intestinal anastomosis protective device | |
| EP3375416B1 (en) | Sphincter-type intestinal valve | |
| JP4347705B2 (en) | Medical intestinal tract manager for stool bypass of patients with bowel surgery | |
| US20210145624A1 (en) | Devices and methods for anchoring a sheath in a tissue cavity | |
| Zaritzky et al. | Magnetic gastrointestinal anastomosis in pediatric patients | |
| US8790322B2 (en) | Stoma coat | |
| Morks et al. | Can intraluminal devices prevent or reduce colorectal anastomotic leakage: a review | |
| WO2013023675A1 (en) | Devices for anchoring an endoluminal sleeve in the gi tract | |
| CN107625573A (en) | Enteron aisle two-chamber fistulization excrement blood shunting device | |
| EP3632345B1 (en) | Apparatus for fixing instrument within intestinal canal | |
| CN202235528U (en) | Transgastric gastrojejunal anastomosis device | |
| CN113855140B (en) | Device and method for preventing anastomotic fistula after colorectal surgery | |
| HARDIE et al. | Use of colostomy to manage rectal disease in dogs | |
| EP4138743A1 (en) | Continuity device for derivative ileostomy | |
| CN211796677U (en) | A degradable intestinal complete bypass stent | |
| KR101511470B1 (en) | Stoma device using artificial bowel extension prothesis | |
| RU140189U1 (en) | ARTIFICIAL BLADDER SPINTER | |
| CN120131265B (en) | Fistula device is prevented to intestinal postoperative | |
| CN102475593A (en) | Biodegradable enterostomy device | |
| Ray et al. | Long segment “Hanging-snout” end ileosotmy a safe “Surgical disaster mitigating” technique for an “Un-brookeable” end ileum: a study of 23 cases over 12 years | |
| Jain et al. | Rectal Prolapse with Intussusception: A Case Study | |
| Lipscomb | Surgery of the lower urinary tract in dogs: 2. Urethral surgery | |
| Zulkowski | Ostomy terms and definitions-continued |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190816 |
|
| RJ01 | Rejection of invention patent application after publication |